133 related articles for article (PubMed ID: 3207625)
1. Bone marrow lymphoid nodules in myeloproliferative disorders: association with the nonmyelosclerotic phases of idiopathic myelofibrosis and immunological significance.
Cervantes F; Pereira A; Marti JM; Feliu E; Rozman C
Br J Haematol; 1988 Nov; 70(3):279-82. PubMed ID: 3207625
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical evaluation of bone marrow lymphoid nodules in chronic myeloproliferative disorders.
Franco V; Florena AM; Aragona F; Campesi G
Virchows Arch A Pathol Anat Histopathol; 1991; 419(4):261-6. PubMed ID: 1949608
[TBL] [Abstract][Full Text] [Related]
3. [Bone marrow lymphoid follicles in myelofibrosis compared with chronic myelogenous leukaemia (author's transl)].
Hernandez Nieto L; Morey Sureda M; Granena A; Montserrat Costa E; Feliu E; Rozman C
Nouv Rev Fr Hematol (1978); 1979; 21(3):251-6. PubMed ID: 296376
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
Macavei I; Galatâr N
Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis of chronic myeloproliferative diseases based on bone marrow biopsy].
Matolcsy A; Kónya T; Wéber E
Orv Hetil; 1992 Jun; 133(26):1617-20, 1625-6. PubMed ID: 1614699
[TBL] [Abstract][Full Text] [Related]
7. [Histological diagnosis of Ph-negative myeloproliferative neoplasia. An overview].
Campr V
Cesk Patol; 2011 Jul; 47(3):84-93. PubMed ID: 21887923
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic myelofibrosis: a possible role for immune-complexes in the pathogenesis of bone marrow fibrosis.
Cappio FC; Vigliani R; Novarino A; Camussi G; Campana D; Gavosto F
Br J Haematol; 1981 Sep; 49(1):17-21. PubMed ID: 7272228
[TBL] [Abstract][Full Text] [Related]
9. The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies.
Kreft A; Büche G; Ghalibafian M; Buhr T; Fischer T; Kirkpatrick CJ
Acta Haematol; 2005; 113(2):137-43. PubMed ID: 15802893
[TBL] [Abstract][Full Text] [Related]
10. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
[TBL] [Abstract][Full Text] [Related]
11. Histologic criteria for classification and differential diagnosis of chronic myeloproliferative disorders.
Frisch B; Bartl R; Burkhardt R; Jäger K
Haematologia (Budap); 1984; 17(2):209-26. PubMed ID: 6534829
[TBL] [Abstract][Full Text] [Related]
12. The gain-of-function JAK2 V617F mutation shifts the phenotype of essential thrombocythemia and chronic idiopathic myelofibrosis to more "erythremic" and less "thrombocythemic": a molecular, histologic, and clinical study.
Rudzki Z; Sacha T; Stój A; Czekalska S; Wójcik M; Skotnicki AB; Grabowska B; Zduńczyk A; Okoń K; Stachura J
Int J Hematol; 2007 Aug; 86(2):130-6. PubMed ID: 17875526
[TBL] [Abstract][Full Text] [Related]
13. Working classification of chronic myeloproliferative disorders based on histological, haematological, and clinical findings.
Burkhardt R; Bartl R; Jäger K; Frisch B; Kettner G; Mahl G; Sund M
J Clin Pathol; 1986 Mar; 39(3):237-52. PubMed ID: 3457024
[TBL] [Abstract][Full Text] [Related]
14. Myelofibrosis in the myeloproliferative disorders.
Ellis JT; Peterson P
Prog Clin Biol Res; 1984; 154():19-42. PubMed ID: 6382293
[TBL] [Abstract][Full Text] [Related]
15. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
16. A histomorphometric study of haematological disorders with respect to marrow fibrosis and osteosclerosis.
Poulsen LW; Melsen F; Bendix K
APMIS; 1998 Apr; 106(4):495-9. PubMed ID: 9637273
[TBL] [Abstract][Full Text] [Related]
17. Assessment of peripheral blood lymphocyte subsets in idiopathic myelofibrosis.
Cervantes F; Hernández-Boluda JC; Villamor N; Serra A; Montserrat E
Eur J Haematol; 2000 Aug; 65(2):104-8. PubMed ID: 10966169
[TBL] [Abstract][Full Text] [Related]
18. Increased circulating CSF-1 (M-CSF) in myeloproliferative disease: association with myeloid metaplasia and peripheral bone marrow extension.
Gilbert HS; Praloran V; Stanley ER
Blood; 1989 Sep; 74(4):1231-4. PubMed ID: 2669997
[TBL] [Abstract][Full Text] [Related]
19. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification.
Buhr T; Georgii A; Choritz H
Pathol Res Pract; 1993 Mar; 189(2):121-32. PubMed ID: 8321741
[TBL] [Abstract][Full Text] [Related]
20. Marrow fibroblasts from patients with myeloproliferative disorders show increased sensitivity to human serum mitogens.
Kimura A; Katoh O; Kuramoto A
Br J Haematol; 1988 Jun; 69(2):153-6. PubMed ID: 3390390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
